Al Hammadi Holding Company (TADAWUL:4007)

Market Cap	4.02B -41.4%
Revenue (ttm)	1.23B +7.0%
Net Income	241.86M -28.6%
EPS	1.51 -28.7%
Shares Out	160.00M
PE Ratio	16.62
Forward PE	13.44
Dividend	0.80 (3.19%)
Ex-Dividend Date	Mar 30, 2026

Volume	461,890
Average Volume	241,380
Open	25.98
Previous Close	25.50
Day's Range	25.04 - 25.98
52-Week Range	23.42 - 42.20
Beta	0.16
RSI	44.07
Earnings Date	Mar 2, 2026

About TADAWUL:4007

Al Hammadi Holding Company, a healthcare group, provides healthcare services in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It engages in the sale of pharmaceutical products; and provides medical services. The company was formerly known as Al Hammadi Company For Development and Investment and changed its name to Al Hammadi Holding Company in August 2022. Al Hammadi Holding Company was founded in 1985 and is based in Riyadh, the Kingdom of Saudi Arabia.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1985
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4007

Financial Performance

In 2025, TADAWUL:4007's revenue was 1.23 billion, an increase of 6.99% compared to the previous year's 1.15 billion. Earnings were 241.86 million, a decrease of -28.61%.